SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Briefs

Inside Views

Contribute your views! Submit an Inside Views idea to info [at] ip-watch [dot] ch.

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Call For Transparency In The Trans-Pacific Partnership Negotiation

In this post, three US law professors explain a recent call by over 30 legal scholars for the US Trade Representative to increase transparency for the Trans-Pacific Partnership Agreement intellectual property chapter, and their response to Ambassador Kirk’s response that he is “strongly offended” by the suggestion that the negotiation is not adequately transparent already.





Latest Comments
  • David, thank you for the note. It appears there is... »
  • The link to the US proposal seems to be broken, an... »

  • For IPW Subscribers
    A guide to Geneva-based public health and intellectual property organisations. Read More >

    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >


    US Trade Team Responds To Protectionist Pressure In Reports On Trading Partners

    Published on 31 March 2009 @ 9:19 pm

    By and for Intellectual Property Watch

    The Obama administration’s new trade team has quickly come under pressure to focus on protecting United States interests, including enforcement of intellectual property rights, at a time when multilateral institutions urge governments to remain open for the sake of the global economy.

    And in a report on trade barriers to US exports released today as well as its recently released trade policy agenda, the Office of the US Trade Representative (USTR) has responded to these pressures, claiming other nations’ protectionist instincts as their target.

    USTR, now headed by Ron Kirk, releases several key documents every spring outlining its plans and targets among foreign trading partners. These reports give an indication of the level of protectionism and enforcement focus the administration has chosen to embrace. No indications appeared to be given of barriers to US promotion of technology transfer in least-developed countries as mandated under World Trade Organization rules.

    Tuesday’s National Trade Estimates report highlights trade barriers for all types US products, including intellectual property rights. USTR’s trade agenda for the coming year was issued in February. These are to be followed at the end of April by the Special 301 report listing countries that USTR, based on information mainly from US industry, determines not to be adequately protecting US intellectual property rights.

    Kirk said that the NTE Report and swift action by USTR will advance US economic recovery efforts, USTR said.

    The 2009 NTE report, available here, covers 10 broad trade categories and offers specifics on barriers to trade in US intellectual property, and focuses on strong enforcement and protection measures.

    The report found concerns about IP rights in a variety of countries, including major trading partners, with numerous references to alleged barriers to entry or access for US brand-name pharmaceuticals, drawn directly from US pharmaceutical industry claims. It was unclear whether USTR had confirmed such claims itself.

    In Brazil, it found progress in IP rights and biotechnology, and “significant” progress in other IP areas. It continued to raise concern about Brazil’s process for examining pharmaceutical patent applications, criticising the country for involving its health ministry (ANVISA) in drug patent decisions. “ANVISA’s role in reviewing pharmaceutical patent applications remains non-transparent and has contributed to an increasing backlog in the issuance of patents,” the report said.

    In Canada, USTR directly cited US industry complaints about competing, lower-priced generic drugs as barriers. “The US pharmaceutical industry has expressed concern with the nature of infringement-related proceedings in conjunction with the approval of copies of patented drugs,” USTR said. “The industry has also expressed concerns related to draft pharmaceutical pricing guidelines, specifically with respect to the regulatory burden that would be placed on pharmaceutical manufacturers.”

    Chile was listed for having “yet to establish a consistently effective and transparent system to address the concerns of patent holders, who report that Chile has permitted the marketing of unauthorised copies of patented pharmaceutical products.”

    China was a major target of criticism as usual, having “continued to demonstrate little success in actually enforcing its IPR laws and regulations.”

    “Weaknesses in China’s enforcement system – criminal, civil, and administrative – contribute to China’s poor IPR enforcement record,” USTR said. One concern is China’s alleged maintenance of import and distribution restrictions.

    Again citing US industry, USTR said, “Right holders have pointed to a number of continuing deficiencies in China’s criminal measures.” For example, it said, “procedural burdens, such as an inability to investigate based on suspicion of criminality, also weaken the criminal IPR system.”

    In addition, USTR asserted that “IPR enforcement is hampered by a lack of coordination among Chinese government ministries and agencies, and between sub-national authorities and the central government, a lack of training, resource constraints, lack of transparency in the enforcement process and its outcomes, and local protectionism and corruption.” Another concern in China is fees associated with the “filing, issuance, and maintenance of a patent over its lifespan far exceed those in the United States,” it said.

    India was seen as still a “major” problem country for IP rights, and its 2005 patent law continues to lack certain key elements on patent protection, USTR said. It also took a jab at India’s pre-grant opposition rules, and said Indian law does not sufficiently protect pharmaceutical test data. USTR also levelled criticism on India’s judicial system in relation to IP enforcement.

    Russia was named for a litany of alleged problems from high rates of piracy and counterfeiting to cybersquatting website addresses not trademarked in Russia. “The United States is working to ensure that Russia takes appropriate actions to protect intellectual rights and address piracy and counterfeiting,” it said. “In addition, the United States is reviewing Russia’s status as a beneficiary country under the US Generalized System of Preferences (GSP) programme [which gives unilateral trade benefits for exporting to the US market]. Russia was also on the 2008 Special 301 Priority Watch List and was subject to an Out-Of-Cycle Review.”

    Thailand, which has come under pressure in recent years for using international trade rules allowing it to produce cheaper versions of patented drugs, was criticised for industry allegations of backlog on patent applications – something of which the United States also is guilty. “US industry notes that delays in patent issuance are a significant problem,” the report said. “Patent examinations can often take five years or more, indicating that Thailand’s patent office lacks sufficient resources to keep up with the volume of applications.”

    “The US pharmaceutical industry has expressed concerns regarding the issuance of compulsory licences on patented drugs by Thailand’s Ministry of Public Health,” USTR said.

    Pressure from Congressional Democrats

    On Monday, senior Democrats (the majority party) in the US House of Representatives sent a letter to President Obama urging the administration to more strictly enforce US rights under international trade agreements. The Democratic letter signed by 16 members was led by House Way and Means Committee Chair Charles Rangel of New York and Trade Subcommittee Chair Sander Levin of Michigan.

    The 26 March letter asserts that enforcement was lacking under the free-market-oriented Bush administration, which they say contributed to the largest trade deficits on record and helped lead to the current global crisis. The congressional members called upon the current administration to “systematically improve its ability to eliminate barriers and open foreign markets to US exporters.”

    Enforcement could help reduce the exorbitant US trade deficit, they argued, and the administration is encouraged to instruct USTR to “take appropriate action” with key trading partners to get results.

    A 30-page appendix to the Democrats’ letter lists a wide range of recommended actions to be taken under a variety of trade agreements, including those related to IP rights – specifically copyright and some trademarks. On IP, they targeted leading trading partners Canada, China, the European Union (France), Mexico and Russia. Proposed actions include pursuing negotiations for an Anti-Counterfeiting Trade Agreement, and many suggest potential violations of World Trade Organization rules.

    Canada was criticised for failure to protect US copyrighted content online and exports of copyright-evasion equipment; China for market access restrictions and a range of piracy activities allegedly valued at $3.5 billion in 2006; France for draft requirements for companies to reveal their technological protection measures; Mexico for failure to protect US movies and music; and Russia’s continued trade barriers and lack of protection for copyrighted works online. With Russia, they suggested penalties such as removing unilateral trade benefits.

    Trade Policy Agenda

    USTR in February presented its 2009 Trade Policy Agenda and 2008 Annual Report outlining its priorities for the upcoming year and assessing last year’s efforts in the ambit of trade. The trade policy agenda is available here.

    While restating “steadfast support” for multilateral trade mechanisms, as well as its bilateral agreements with trade partners, USTR in the report voiced concern at lax IP protection in a number of countries. These reservations are to be further elaborated in the Special 301 review. Twinned to the USTR trade agenda, the Special 301 provides the most reliable indication of US positioning on trade and IP policy issues.

    Looking at the 2009 trade policy agenda, the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) remains a priority as the US seeks to “aggressively pursue additional support for the ‘joint proposal’ in 2009,” referring to a different approach to a geographical indications register than proposed by the European Union.

    While remaining inflexible on the issue of the registration of geographical indications for wines and spirits, USTR called for a “more pragmatic approach” from their counterparts in the EU. Moreover, the US will continue to “resolve differences through consultations and use of dispute settlement procedures; continue its efforts to ensure that developing country members fully implement the TRIPS agreement; and engage in constructive dialogue regarding the technical assistance and capacity-related needs of developing countries in connection with TRIPS agreement implementation.”

    Intent on providing “adequate legal regimes and enforcement systems to better combat counterfeiting and piracy,” the report also highlights significant improvement in IP rights protection in countries which previously had been designated as errant in the 2008 Special 301 Review. The USTR will, as in past years, continue to work on the implementation of stronger IP protection regimes in countries with whom it the US has concluded free trade agreements.

    Other nations and regions highlighted by USTR in the trade agenda included:

    APEC
    US will work with other nations in the Asia Pacific Economic Cooperation to put in place legal regimes and enforcement systems to better combat counterfeiting and piracy.

    Argentina
    A low level of IP protection and enforcement remains a “source of friction” in its trade relationship with the United States.

    Brazil
    Progress in enhancing the effectiveness of intellectual property enforcement in Brazil, particularly with respect to pirated audiovisual goods. But USTR said “shortcomings” in protection and enforcement, such as the “large backlogs of patent and trademark applications and the involvement of Brazil’s Health Ministry (ANVISA) in the examination process of patent applications for pharmaceuticals, continue to represent issues for US IPR holders.” A memorandum of understanding was concluded in 2008 between the USPTO and Brazil’s national IP office on continued technical cooperation on IP issues, such as patent and trademark examination training and information sharing.

    Canada
    Similarly to 2007, US intellectual property owners remain concerned about Canada’s weak border measures and general enforcement efforts.

    Chile
    The USTR raised concern over a decline in IP protection and in particular the weak protection afforded to patent and test data in Chile; a technical review of IP implementation measures in the bilateral free trade agreement was scheduled for the first quarter of 2009.

    China
    The US will continue a “robust set of formal and informal meetings and dialogues” with China and “will not hesitate to invoke the dispute settlement mechanism at the WTO” when dialogue proves unsuccessful. In addressing the manifold challenges, the US continues to work closely with industry and devotes “considerable staff and resources, both in Washington and Beijing.”

    India
    Continued cooperation in improvements of its IP rights regime is mediated through the US-India Trade Policy Forum’s Focus Group on Innovation and Creativity, the US Commerce Department-led High Technology Cooperation Group and the IP attaché stationed in New Delhi. The US seeks a strengthening of India’s patent regime; to remedy problems related to protection of digital works on the internet; and increased protection and enforcement against piracy and counterfeiting. It also needs to clarify the scope of patentable subject matter under its patent law, USTR said.

    Mexico
    Though concern exists in view of significant IP rights violations, there have been some signs of progress and change: an extensive set of IP laws has been introduced and a bill proposing to give the Procuraduría General de la República the power to prosecute intellectual property crimes ex officio is awaiting action by the Senate.

    Russia
    The poor enforcement of IP rights in Russia is a “pervasive problem.” In 2008, the US embassy in Moscow coordinated or participated in several IPR training programs.

    Taiwan
    In January 2009, Taiwan was removed from the Special 301 watch list as a result of progress on protection and enforcement of IPRs. The US has “strongly encouraged Taiwan’s passage of legislation” for the creation of specialised intellectual property courts and will monitor the implementation of this measure.

    Thailand
    Political volatility and instability in Thailand has marred the implementation of stronger enforcement measures. In 2009, the US will continue monitoring and evaluating existing IP agreements and will look at ways to strengthen bilateral relations.

    Turkey
    Improvements in enforcement measures in the area of copyright led the USTR to move Turkey from “priority watch list” to “watch list” status during the 2008 Special 301 review. The absence of an adequate system for preventing generic drugs that infringe Turkish patents of US pharmaceutical companies from receiving marketing approval in Turkey remains a source of concern.

    Special 301 Review 2008
    The 2008 Special 301 Special Review highlighted the counterfeiting of pharmaceuticals and consumer safety as areas of growing concern.

    William New may be reached at wnew@ip-watch.ch.

    Dirshaye Abate may be reached at info@ip-watch.ch.

     

    Comments

    1. Pete Murphy says:

      Our enormous trade deficit is rightly of growing concern to Americans. Since leading the global drive toward trade liberalization by signing the Global Agreement on Tariffs and Trade in 1947, America has been transformed from the wealthiest nation on earth – its preeminent industrial power – into a skid row bum, literally begging the rest of the world for cash to keep us afloat. It’s a disgusting spectacle. Our cumulative trade deficit since 1976, financed by a sell-off of American assets, exceeds $9.1 trillion. What will happen when those assets are depleted? Today’s recession is the answer.

      Why? The American work force is the most productive on earth. Our product quality, though it may have fallen short at one time, is now on a par with the Japanese. Our workers have labored tirelessly to improve our competitiveness. Yet our deficit continues to grow. Our median wages and net worth have declined for decades. Our debt has soared.

      Clearly, there is something amiss with “free trade.” The concept of free trade is rooted in Ricardo’s principle of comparative advantage. In 1817 Ricardo hypothesized that every nation benefits when it trades what it makes best for products made best by other nations. On the surface, it seems to make sense. But is it possible that this theory is flawed in some way? Is there something that Ricardo didn’t consider?

      At this point, I should introduce myself. I am author of a book titled “Five Short Blasts: A New Economic Theory Exposes The Fatal Flaw in Globalization and Its Consequences for America.” My theory is that, as population density rises beyond some optimum level, per capita consumption begins to decline. This occurs because, as people are forced to crowd together and conserve space, it becomes ever more impractical to own many products. Falling per capita consumption, in the face of rising productivity (per capita output, which always rises), inevitably yields rising unemployment and poverty.

      This theory has huge ramifications for U.S. policy toward population management (especially immigration policy) and trade. The implications for population policy may be obvious, but why trade? It’s because these effects of an excessive population density – rising unemployment and poverty – are actually imported when we attempt to engage in free trade in manufactured goods with a nation that is much more densely populated. Our economies combine. The work of manufacturing is spread evenly across the combined labor force. But, while the more densely populated nation gets free access to a healthy market, all we get in return is access to a market emaciated by over-crowding and low per capita consumption. The result is an automatic, irreversible trade deficit and loss of jobs, tantamount to economic suicide.

      One need look no further than the U.S.’s trade data for proof of this effect. Using 2006 data, an in-depth analysis reveals that, of our top twenty per capita trade deficits in manufactured goods (the trade deficit divided by the population of the country in question), eighteen are with nations much more densely populated than our own. Even more revealing, if the nations of the world are divided equally around the median population density, the U.S. had a trade surplus in manufactured goods of $17 billion with the half of nations below the median population density. With the half above the median, we had a $480 billion deficit!

      Our trade deficit with China is getting all of the attention these days. But, when expressed in per capita terms, our deficit with China in manufactured goods is rather unremarkable – nineteenth on the list. Our per capita deficit with other nations such as Japan, Germany, Mexico, Korea and others (all much more densely populated than the U.S.) is worse. My point is not that our deficit with China isn’t a problem, but rather that it’s exactly what we should have expected when we suddenly applied a trade policy that was a proven failure around the world to a country with one fifth of the world’s population.

      Ricardo’s principle of comparative advantage is overly simplistic and flawed because it does not take into consideration this population density effect and what happens when two nations grossly disparate in population density attempt to trade freely in manufactured goods. While free trade in natural resources and free trade in manufactured goods between nations of roughly equal population density is indeed beneficial, just as Ricardo predicts, it’s a sure-fire loser when attempting to trade freely in manufactured goods with a nation with an excessive population density.

      If you‘re interested in learning more about this important new economic theory, then I invite you to visit either of my web sites at OpenWindowPublishingCo.com or PeteMurphy.wordpress.com where you can read the preface, join in the blog discussion and, of course, buy the book if you like. (It’s also available at Amazon.com.)

      Please forgive me for the somewhat spammish nature of the previous paragraph, but I don’t know how else to inject this new theory into the debate about trade without drawing attention to the book that explains the theory.

      Pete Murphy
      Author, “Five Short Blasts”


    Leave a Reply

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website. By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

    By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

    2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

    3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

    4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

    5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

    6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

    7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

    8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

    9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.